Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›Novartis Ireland Limited
Medicines register · Ireland

Novartis Ireland Limited — licensed medicines

46 medicines held by Novartis Ireland Limited on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 08 Oct 2026, 03:31 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
46 of 10,296 medicines
Download
Medicine
Active substance
Licence holder
Status
Cataflam 50mg Coated Tablets PA0896/004/001
Diclofenac potassium
Novartis Ireland Limited
Marketed
Certican 0.25mg Tablets PA0896/005/001
Everolimus
Novartis Ireland Limited
Not marketed
Certican 0.75mg Tablets PA0896/005/003
Everolimus
Novartis Ireland Limited
Not marketed
Ciloxan 3 mg/ml ear drops, solution PA0896/006/001
Ciprofloxacin
Novartis Ireland Limited
Marketed
Co-Diovan 160 mg/12.5 mg film-coated tablets PA0896/007/002
Valsartan, Hydrochlorothiazide
Novartis Ireland Limited
Marketed
Co-Diovan 160 mg/25 mg film-coated tablets PA0896/007/003
Valsartan, Hydrochlorothiazide
Novartis Ireland Limited
Marketed
Co-Diovan 320 mg/12.5 mg film-coated tablets PA0896/007/004
Valsartan, Hydrochlorothiazide
Novartis Ireland Limited
Marketed
Co-Diovan 320 mg/25 mg film-coated tablets PA0896/007/005
Valsartan, Hydrochlorothiazide
Novartis Ireland Limited
Marketed
Co-Diovan 80 mg/12.5 mg film-coated tablets PA0896/007/001
Valsartan, Hydrochlorothiazide
Novartis Ireland Limited
Marketed
Diovan 160 mg film-coated tablets PA0896/009/002
Valsartan
Novartis Ireland Limited
Marketed
Diovan 320 mg film-coated tablets PA0896/009/004
Valsartan
Novartis Ireland Limited
Marketed
Diovan 3mg/ml oral solution PA0896/009/005
Valsartan
Novartis Ireland Limited
Marketed
Diovan 40 mg film-coated tablets PA0896/009/003
Valsartan
Novartis Ireland Limited
Marketed
Diovan 80 mg film-coated tablets PA0896/009/001
Valsartan
Novartis Ireland Limited
Marketed
Femara 2.5 mg film-coated tablets PA0896/012/001
Letrozole
Novartis Ireland Limited
Not marketed
Lioresal 10 mg Tablets PA0896/017/001
Baclofen
Novartis Ireland Limited
Marketed
Lioresal 5mg/5ml Oral solution PA0896/017/002
Baclofen
Novartis Ireland Limited
Marketed
Luxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injection EU/1/18/1331/001
VORETIGENE NEPARVOVEC
Novartis Ireland Limited
—
Maxidex 0.1% w/v Eye Drops, Suspension PA0896/018/001
Dexamethasone
Novartis Ireland Limited
Marketed
Maxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspension PA0896/019/001
Dexamethasone, Polymyxin b sulfate, Neomycin sulfate
Novartis Ireland Limited
Not marketed
Myfortic 180 mg gastro-resistant tablets PA0896/023/001
Mycophenolic acid
Novartis Ireland Limited
Marketed
Myfortic 360 mg gastro-resistant tablets PA0896/023/002
Mycophenolic acid
Novartis Ireland Limited
Marketed
Neoral 100 mg/ml concentrate for oral solution PA0896/024/004
Ciclosporin
Novartis Ireland Limited
Marketed
Neoral 100mg Soft Capsules PA0896/024/003
Ciclosporin
Novartis Ireland Limited
Marketed
Neoral 25 mg Soft Capsules PA0896/024/001
Ciclosporin
Novartis Ireland Limited
Marketed
Neoral 50mg Soft Capsules PA0896/024/002
Ciclosporin
Novartis Ireland Limited
Marketed
Sandimmun 50 mg/ml Concentrate for Solution for Infusion PA0896/027/002
Ciclosporin
Novartis Ireland Limited
Marketed
SANDOSTATIN 100 microgram/1ml, solution for injection/infusion PA0896/028/002
Octreotide
Novartis Ireland Limited
Marketed
SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion PA0896/028/001
Octreotide
Novartis Ireland Limited
Marketed
SANDOSTATIN 500 microgram/1 ml, solution for injection/infusion PA0896/028/003
Octreotide
Novartis Ireland Limited
Marketed
Sandostatin LAR 10 mg powder and solvent for suspension for injection PA0896/028/004
Octreotide
Novartis Ireland Limited
Marketed
Sandostatin LAR 20 mg powder and solvent for suspension for injection PA0896/028/005
Octreotide
Novartis Ireland Limited
Marketed
Sandostatin LAR 30 mg powder and solvent for suspension for injection PA0896/028/006
Octreotide
Novartis Ireland Limited
Marketed
Tegretol 100mg Tablets PA0896/030/002
Carbamazepine
Novartis Ireland Limited
Marketed
Tegretol 100mg/5ml Oral Suspension PA0896/030/001
Carbamazepine
Novartis Ireland Limited
Marketed
Tegretol 200mg Tablets PA0896/030/003
Carbamazepine
Novartis Ireland Limited
Marketed
Tegretol 400mg Tablets PA0896/030/004
Carbamazepine
Novartis Ireland Limited
Marketed
Tegretol SR 200mg prolonged release tablets PA0896/030/005
Carbamazepine
Novartis Ireland Limited
Marketed
Tegretol SR 400mg prolonged release tablets PA0896/030/006
Carbamazepine
Novartis Ireland Limited
Marketed
Trileptal 150 mg Film-coated tablets PA0896/033/001
Oxcarbazepine
Novartis Ireland Limited
Marketed
Trileptal 300 mg Film-coated tablets PA0896/033/002
Oxcarbazepine
Novartis Ireland Limited
Marketed
Trileptal 60 mg/ml Oral Suspension PA0896/033/004
Oxcarbazepine
Novartis Ireland Limited
Marketed
Trileptal 600 mg Film-coated tablets PA0896/033/003
Oxcarbazepine
Novartis Ireland Limited
Marketed
Voltarol 50 mg Gastro-Resistant Tablets PA0896/034/001
Diclofenac sodium
Novartis Ireland Limited
Marketed
Voltarol Retard 100 mg Film-coated Prolonged Release Tablets PA0896/034/002
Diclofenac sodium
Novartis Ireland Limited
Marketed
Voltarol Retard 75 mg Film-coated Prolonged-release Tablets PA0896/034/003
Diclofenac sodium
Novartis Ireland Limited
Marketed
Showing 1–46 of 46
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 8 October 2026. https://priyalifescience.com/medicines/company/novartis-ireland-limited

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.